Skip to Main Content

Paper Details

BRAF Modulates Lipid Use and Accumulation.
Cancers (Basel)
3
2022
BRAF, BRAF V600, BRAF V600E, BRAF WT, NIH3T3 cells, PUFAs, V600, cancer, cancers, fatty acids, lysophosphatidic acid, melanoma, non-transformed NIH3T3 cell line, patients, polyunsaturated fatty acids, sphingomyelin
Author NameAffiliation
Davide StefanoniUniversity of Colorado School of Medicine
Davide StefanoniUniversity of Colorado School of Medicine
Julie A ReiszUniversity of Colorado School of Medicine
Martin D McCarterUniversity of Colorado School of Medicine
Angelo D'AlessandroUniversity of Colorado School of Medicine
Angelo D'AlessandroUniversity of Colorado School of Medicine
William A RobinsonUniversity of Colorado School of Medicine
William A RobinsonUniversity of Colorado School of Medicine
  • 1 - 8

Datasets

Release 1.2